Shibo Liu
-
- Cancer, Lipids, and Metabolism 2
-
- RNA modifications and cancer 3
- RNA Research and Splicing 3
- Epigenetics and DNA Methylation 2
-
- Peptidase Inhibition and Analysis 2
-
- Mesenchymal stem cell research 4
-
- Adipokines, Inflammation, and Metabolic Diseases 3
-
- Adipose Tissue and Metabolism 2
- Journals
- Biomaterials (1 paper)Cell Reports (1 paper)The International Journal of Biochemistry & Cell Biology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Shibo Liu
20 papers receiving 235 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 49
- Molecular Biology 130
- Clinical Biochemistry 12
- Geriatrics and Gerontology 6
- Oncology 34
Countries citing papers authored by Shibo Liu
This map shows the geographic impact of Shibo Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shibo Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shibo Liu more than expected).
Fields of papers citing papers by Shibo Liu
This network shows the impact of papers produced by Shibo Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shibo Liu. The network helps show where Shibo Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shibo Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 7 | |
| 8 | 2024 | 39 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 3 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2022 | 30 | |
| 15 | 2022 | 6 | |
| 16 | 2022 | 7 | |
| 17 | 2019 | 20 | |
| 18 | 2016 | 28 | |
| 19 | 2016 | 43 | |
| 20 | 2016 | 12 |
About Shibo Liu
Shibo Liu is a scholar working on Genetics, Transplantation and Cancer Research, having authored 21 papers that have together received 236 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (4 papers), RNA modifications and cancer (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), RNA Research and Splicing (3 papers), Epigenetics and DNA Methylation (2 papers), Cancer, Lipids, and Metabolism (2 papers), Adipose Tissue and Metabolism (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Cancer Research (49 citations), Molecular Biology (130 citations) and Clinical Biochemistry (12 citations). Shibo Liu has collaborated with scholars based in China and United States. Frequent co-authors include En Luo, Hanghang Liu, Pei Hu, Yong Li, Yao Liu, Fei Zhang, Yingbin Liu, Haibin Liang, Shuai Zhao and Runfa Bao. Their work appears in journals such as Biomaterials, Cell Reports and The International Journal of Biochemistry & Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.